Biotechnology Stocks I: Compare Returns of S&P 500 to Ultragenyx Pharmaceutical Inc. (RARE)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Compare Returns for S&P 500 and RARE | ||
|---|---|---|
| S&P 500 | RARE | |
| Start Date | Jan-01-2015 | Jan-30-2015 |
| Start Price | $2,736.83 | $58.10 |
| End Date | Jan-01-2025 | Jan-17-2025 |
| End Price | $5,868.55 | $40.00 |
| Number Monthly Prices | 121 | 121 |
| Min Date | Feb-01-2016 | Oct-31-2023 |
| Min Price | $2,532.94 | $35.40 |
| Max Date | Dec-01-2024 | Feb-26-2021 |
| Max Price | $6,010.09 | $141.54 |
| Total Return | 114.43% | -31.15% |
| Annualized Return | 7.86% | -3.63% |
| Current Value of $1,000 Purchase | $2,144 | $688 |
| Number Returns | 7,260 | 7,260 |
| Average Return | 32.11% | -4.60% |
| Minimum Return | -25.54% | -74.99% |
| Maximum Return | 137.28% | 256.97% |
| Number Profitable Returns | 6,544 | 2,560 |
| Percent Profitable Returns | 90.14% | 35.26% |
| Number Unprofitable Returns | 716 | 4,700 |
| Percent Unprofitable Returns | 9.86% | 64.74% |
| Profitable to Unprofitable Returns Ratio | 9.14 | 0.54 |
RARE Performance Table and Chart
RARE Dollar-cost Average
RARE Trendline Chart
RARE Moving Average Chart
RARE Stock Return Map - See Patterns of Gains and Losses
RARE Stock Returns/Purchase Dates